Discounted Cash Flow
Accendra Health Inc./Va/
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $9.7b | $108.8m | $166.6m | 1.1% | $1.76 |
| 2017 | $9.3b (-4.2%) | $72.8m (-33.1%) | $22.2m (-86.7%) | 0.8% (-30.2%) | $1.03 (-41.5%) |
| 2018 | $9.8b (5.6%) | $-437.0m (-700.3%) | $70.7m (219.1%) | -4.4% (-668.6%) | $0.86 (-16.5%) |
| 2019 | $9.2b (-6.4%) | $-62.4m (85.7%) | $123.7m (74.9%) | -0.7% (84.8%) | $-1.03 (-219.8%) |
| 2020 | $8.5b (-7.9%) | $29.9m (147.9%) | $288.8m (133.5%) | 0.4% (152.0%) | $0.47 (145.6%) |
| 2021 | $9.8b (15.4%) | $221.6m (641.8%) | $83.2m (-71.2%) | 2.3% (542.9%) | $3.05 (548.9%) |
| 2022 | $10.0b (1.7%) | $22.4m (-89.9%) | $166.9m (100.6%) | 0.2% (-90.1%) | $0.30 (-90.2%) |
| 2023 | $10.3b (3.8%) | $-41.3m (-284.5%) | $549.8m (229.4%) | -0.4% (-277.7%) | $-0.54 (-280.0%) |
| 2024 | $10.7b (3.6%) | $-362.7m (-778.2%) | $-49.4m (-109.0%) | -3.4% (-748.0%) | $-4.73 (-775.9%) |
| 2025 | $2.8b (-74.2%) | $-1.1b (-203.5%) | $-447.2m (-805.9%) | -39.8% (-1075.7%) | $-14.31 (-202.5%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.